Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

Self-identified gadolinium toxicity: comparison of gadolinium in bone and urine to healthy gadolinium-based contrast agent exposed volunteers.

Lord ML, McNeill FE, Gräfe JL, Noseworthy MD, Chettle DR.

Physiol Meas. 2018 Nov 28;39(11):115008. doi: 10.1088/1361-6579/aaedc6.

PMID:
30485255
2.

Observed Deposition of Gadolinium in Bone Using a New Noninvasive in Vivo Biomedical Device: Results of a Small Pilot Feasibility Study.

Lord ML, Chettle DR, Gräfe JL, Noseworthy MD, McNeill FE.

Radiology. 2018 Apr;287(1):96-103. doi: 10.1148/radiol.2017171161. Epub 2017 Dec 13.

PMID:
29237148
3.

The decrease in population bone lead levels in Canada between 1993 and 2010 as assessed by in vivo XRF.

McNeill FE, Fisher M, Chettle DR, Inskip M, Healey N, Bray R, Webber CE, Manton WI, Marro L, Arbuckle TE.

Physiol Meas. 2017 Dec 28;39(1):015005. doi: 10.1088/1361-6579/aa904f.

PMID:
28967867
4.

Coherent normalization for in vivo measurements of gadolinium in bone.

Keldani Z, Lord ML, McNeill FE, Chettle DR, Gräfe JL.

Physiol Meas. 2017 Sep 21;38(10):1848-1858. doi: 10.1088/1361-6579/aa87f0.

PMID:
28832339
5.

Performance comparison of two Olympus InnovX handheld x-ray analyzers for feasibility of measuring arsenic in skin in vivo - Alpha and Delta models.

Desouza ED, Gherase MR, Fleming DE, Chettle DR, O'Meara JM, McNeill FE.

Appl Radiat Isot. 2017 May;123:82-93. doi: 10.1016/j.apradiso.2017.02.029. Epub 2017 Feb 20.

PMID:
28260610
6.

Age and sex influence on bone and blood lead concentrations in a cohort of the general population living in Toronto.

Behinaein S, Chettle DR, Fisher M, Manton WI, Marro L, Fleming DE, Healey N, Inskip M, Arbuckle TE, McNeill FE.

Physiol Meas. 2017 Mar;38(3):431-451. doi: 10.1088/1361-6579/aa57b9. Epub 2017 Jan 9.

PMID:
28067216
7.

Confirming improved detection of gadolinium in bone using in vivo XRF.

Lord ML, McNeill FE, Gräfe JL, Galusha AL, Parsons PJ, Noseworthy MD, Howard L, Chettle DR.

Appl Radiat Isot. 2017 Feb;120:111-118. doi: 10.1016/j.apradiso.2016.12.011. Epub 2016 Dec 11.

PMID:
27987464
8.

In vivo neutron activation study of the short-term kinetic behaviour of sodium and chlorine in the human hand.

Mohseni HK, Cowan D, Chettle DR, Priest ND, Atanackovic J, Byun SH, Prestwich WV.

Physiol Meas. 2016 Nov;37(11):N76-N83. Epub 2016 Oct 6.

PMID:
27710928
9.

Optimization of data analysis for the in vivo neutron activation analysis of aluminum in bone.

Mohseni HK, Matysiak W, Chettle DR, Byun SH, Priest N, Atanackovic J, Prestwich WV.

Appl Radiat Isot. 2016 Oct;116:34-40. doi: 10.1016/j.apradiso.2016.07.004. Epub 2016 Jul 9.

PMID:
27474904
10.

A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis.

Mohseni HK, Cowan D, Chettle DR, Milić AP, Priest N, Matysiak W, Atanackovic J, Byun SH, Prestwich WV.

J Alzheimers Dis. 2016 Jun 18;53(3):933-42. doi: 10.3233/JAD-160194.

PMID:
27340850
11.

A phantom-based feasibility study for detection of gadolinium in bone in-vivo using X-ray fluorescence.

Lord ML, McNeill FE, Gräfe JL, Noseworthy MD, Chettle DR.

Appl Radiat Isot. 2016 Jun;112:103-9. doi: 10.1016/j.apradiso.2016.03.021. Epub 2016 Mar 21.

PMID:
27019028
12.

Modeling elemental strontium in human bone based on in vivo x-ray fluorescence measurements in osteoporotic females self-supplementing with strontium citrate.

Moise H, Chettle DR, Pejović-Milić A.

Physiol Meas. 2016 Mar;37(3):429-41. doi: 10.1088/0967-3334/37/3/429. Epub 2016 Feb 24.

PMID:
26910208
13.

A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects.

Mohseni HK, Chettle DR.

J Alzheimers Dis. 2016;50(4):913-26. doi: 10.3233/JAD-150595. Review.

PMID:
26890739
14.

Development of a (170)Tm source for mercury monitoring studies in humans using XRF.

Timmaraju KP, Fajurally BN, Armstrong AF, Chettle DR.

Appl Radiat Isot. 2016 Apr;110:70-73. doi: 10.1016/j.apradiso.2015.12.066. Epub 2016 Jan 1.

PMID:
26773819
15.

Feasibility of measuring arsenic and selenium in human skin using in vivo x-ray fluorescence (XRF)--a comparison of methods.

Shehab H, Desouza ED, O'Meara J, Pejović-Milić A, Chettle DR, Fleming DE, McNeill FE.

Physiol Meas. 2016 Jan;37(1):145-61. doi: 10.1088/0967-3334/37/1/145. Epub 2015 Dec 18.

PMID:
26683849
16.

Physiologically based modeling of lead kinetics: a pilot study using data from a Canadian population.

MacMillan JW, Behinaein S, Chettle DR, Inskip M, McNeill FE, Manton WI, Healey N, Fisher M, Arbuckle TE, Fleming DE.

Environ Sci Process Impacts. 2015 Dec;17(12):2122-33. doi: 10.1039/c5em00517e.

PMID:
26565959
17.

Identification of oxygen-19 during in vivo neutron activation analysis of water phantoms.

Tahir SN, Chettle DR.

Physiol Meas. 2015 Dec;36(12):N127-34. doi: 10.1088/0967-3334/36/12/N127. Epub 2015 Oct 26.

PMID:
26502270
18.

Feasibility of measuring selenium in humans using in vivo neutron activation analysis.

Tahir SN, Chettle DR, Byun SH, Prestwich WV.

Physiol Meas. 2015 Nov;36(11):2217-30. doi: 10.1088/0967-3334/36/11/2217. Epub 2015 Sep 22.

PMID:
26393663
19.

Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women.

Wong AK, Beattie KA, Bhargava A, Cheung M, Webber CE, Chettle DR, Papaioannou A, Adachi JD; Canadian Multicentre Osteoporosis Study (CaMos) Research Group.

Bone. 2015 Oct;79:58-64. doi: 10.1016/j.bone.2015.05.010. Epub 2015 May 15.

20.

Measurements of fluorine in contemporary urban Canadians: a comparison of the levels found in human bone using in vivo and ex vivo neutron activation analysis.

Mostafaei F, McNeill FE, Chettle DR, Wainman BC, Pidruczny AE, Prestwich WV.

Physiol Meas. 2015 Mar;36(3):465-87. doi: 10.1088/0967-3334/36/3/465. Epub 2015 Feb 11.

PMID:
25669130

Supplemental Content

Loading ...
Support Center